We are analyzing https://link.springer.com/article/10.1007/s11523-016-0454-5.

Title:
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma | Targeted Oncology
Description:
Background Patients with diabetes are at increased risk of developing hepatocellular carcinoma (HCC) and have a poorer prognosis as compared to non-diabetics when HCC occurs. Diabetics with non-HCC cancers are at higher risk of toxicity related to systemic therapy, but data on HCC are lacking. Objective The aim of this study was to evaluate safety and effectiveness of sorafenib in HCC patients according to the presence/absence of diabetes. Patients and Methods From October 2008 to June 2014, 313 patients with HCC treated with sorafenib were enrolled. The patients were staged according to the BCLC system. Treatment response was evaluated according to the mRECIST criteria. The main evaluated outcomes were the overall survival and the safety in the two groups. Results Patients were divided in two groups: 80 diabetics (DIAB) and 233 nondiabetics (nDIAB). The median treatment duration was 4 months in DIAB and 3 months in nDIAB. Main adverse events occurred with comparable frequency in both groups, with the exception of rash, that was more frequent among DIAB than in nDIAB: 27.5 % vs 17.6 % (P = .047). The median overall survival was 9 months in nDIAB and 10 months in DIAB group (P = .535). Median time-to-progression (TTP) was longer the in DIAB than the nDIAB group (P = .038). Conclusions Sorafenib was as safe as effective in DIAB and in nDIAB patients. The longer TTP observed among DIAB than in nDIAB patients might suggest a better anticancer effect of sorafenib in patients with diabetes.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

article, pubmed, google, scholar, diabetes, cancer, carcinoma, hepatocellular, patients, cas, sorafenib, risk, study, central, metformin, liver, treatment, diab, ndiab, hcc, content, analysis, data, outcomes, therapy, mellitus, type, ggdc, privacy, cookies, research, costanzo, survival, effect, access, association, clin, oncol, insulin, publish, search, impact, manuscript, giovan, giuseppe, tortora, morisco, response, months, clinical,

Topics {✒️}

month download article/chapter el-serag hb maria guarino & nicola caporaso hyperinsulinaemia-diabetes-cancer link immune-mediated antitumor effect full article pdf increased cancer-related mortality nicola caporaso declare van noord pa de jong-bakker privacy choices/manage cookies related subjects major complications barcelona-2000 easl conference advanced hepatocellular carcinoma diabetes metab rev luigia falco type 2 diabetes 17-year cohort study breast-cancer risk janssen-heijnen mlg le marchand-brustel induces mtor inhibition vegf-dependant plasticity normal adult microvasculature expert opin pharmacother ethics declarations funding developing hepatocellular carcinoma unresectable hepatocellular carcinoma important intellectual content mol cell biol cell-cycle arrest mol cancer ther author information authors chronic liver disease semin liver dis clin genitourin cancer article log llovet jm european economic area compensated cirrhosis due conditions privacy policy accepting optional cookies clin cancer res single institution experience world health organization antitumor agent compensated viral cirrhosis check access instant access

Questions {❓}

Metformin in cancer therapy: a new perspective for an old antidiabetic drug?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma
         description:Patients with diabetes are at increased risk of developing hepatocellular carcinoma (HCC) and have a poorer prognosis as compared to non-diabetics when HCC occurs. Diabetics with non-HCC cancers are at higher risk of toxicity related to systemic therapy, but data on HCC are lacking. The aim of this study was to evaluate safety and effectiveness of sorafenib in HCC patients according to the presence/absence of diabetes. From October 2008 to June 2014, 313 patients with HCC treated with sorafenib were enrolled. The patients were staged according to the BCLC system. Treatment response was evaluated according to the mRECIST criteria. The main evaluated outcomes were the overall survival and the safety in the two groups. Patients were divided in two groups: 80 diabetics (DIAB) and 233 nondiabetics (nDIAB). The median treatment duration was 4 months in DIAB and 3 months in nDIAB. Main adverse events occurred with comparable frequency in both groups, with the exception of rash, that was more frequent among DIAB than in nDIAB: 27.5 % vs 17.6 % (P = .047). The median overall survival was 9 months in nDIAB and 10 months in DIAB group (P = .535). Median time-to-progression (TTP) was longer the in DIAB than the nDIAB group (P = .038). Sorafenib was as safe as effective in DIAB and in nDIAB patients. The longer TTP observed among DIAB than in nDIAB patients might suggest a better anticancer effect of sorafenib in patients with diabetes.
         datePublished:2016-08-09T00:00:00Z
         dateModified:2016-08-09T00:00:00Z
         pageStart:61
         pageEnd:67
         sameAs:https://doi.org/10.1007/s11523-016-0454-5
         keywords:
            Overall Survival
            Metformin
            Sorafenib
            Acarbose
            Oral Hypoglycemic Agent
            Oncology
            Biomedicine
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0454-5/MediaObjects/11523_2016_454_Figa_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0454-5/MediaObjects/11523_2016_454_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0454-5/MediaObjects/11523_2016_454_Fig2_HTML.gif
         isPartOf:
            name:Targeted Oncology
            issn:
               1776-260X
               1776-2596
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Giovan Giuseppe Di Costanzo
               affiliation:
                     name:Cardarelli Hospital
                     address:
                        name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Raffaella Tortora
               affiliation:
                     name:Cardarelli Hospital
                     address:
                        name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Filomena Morisco
               affiliation:
                     name:University of Naples “Federico II”
                     address:
                        name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luigi Addario
               affiliation:
                     name:Cardarelli Hospital
                     address:
                        name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Maria Guarino
               affiliation:
                     name:University of Naples “Federico II”
                     address:
                        name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gabriella Cordone
               affiliation:
                     name:Cardarelli Hospital
                     address:
                        name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luigia Falco
               affiliation:
                     name:Cardarelli Hospital
                     address:
                        name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nicola Caporaso
               affiliation:
                     name:University of Naples “Federico II”
                     address:
                        name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma
      description:Patients with diabetes are at increased risk of developing hepatocellular carcinoma (HCC) and have a poorer prognosis as compared to non-diabetics when HCC occurs. Diabetics with non-HCC cancers are at higher risk of toxicity related to systemic therapy, but data on HCC are lacking. The aim of this study was to evaluate safety and effectiveness of sorafenib in HCC patients according to the presence/absence of diabetes. From October 2008 to June 2014, 313 patients with HCC treated with sorafenib were enrolled. The patients were staged according to the BCLC system. Treatment response was evaluated according to the mRECIST criteria. The main evaluated outcomes were the overall survival and the safety in the two groups. Patients were divided in two groups: 80 diabetics (DIAB) and 233 nondiabetics (nDIAB). The median treatment duration was 4 months in DIAB and 3 months in nDIAB. Main adverse events occurred with comparable frequency in both groups, with the exception of rash, that was more frequent among DIAB than in nDIAB: 27.5 % vs 17.6 % (P = .047). The median overall survival was 9 months in nDIAB and 10 months in DIAB group (P = .535). Median time-to-progression (TTP) was longer the in DIAB than the nDIAB group (P = .038). Sorafenib was as safe as effective in DIAB and in nDIAB patients. The longer TTP observed among DIAB than in nDIAB patients might suggest a better anticancer effect of sorafenib in patients with diabetes.
      datePublished:2016-08-09T00:00:00Z
      dateModified:2016-08-09T00:00:00Z
      pageStart:61
      pageEnd:67
      sameAs:https://doi.org/10.1007/s11523-016-0454-5
      keywords:
         Overall Survival
         Metformin
         Sorafenib
         Acarbose
         Oral Hypoglycemic Agent
         Oncology
         Biomedicine
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0454-5/MediaObjects/11523_2016_454_Figa_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0454-5/MediaObjects/11523_2016_454_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11523-016-0454-5/MediaObjects/11523_2016_454_Fig2_HTML.gif
      isPartOf:
         name:Targeted Oncology
         issn:
            1776-260X
            1776-2596
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Giovan Giuseppe Di Costanzo
            affiliation:
                  name:Cardarelli Hospital
                  address:
                     name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Raffaella Tortora
            affiliation:
                  name:Cardarelli Hospital
                  address:
                     name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Filomena Morisco
            affiliation:
                  name:University of Naples “Federico II”
                  address:
                     name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luigi Addario
            affiliation:
                  name:Cardarelli Hospital
                  address:
                     name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Maria Guarino
            affiliation:
                  name:University of Naples “Federico II”
                  address:
                     name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gabriella Cordone
            affiliation:
                  name:Cardarelli Hospital
                  address:
                     name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luigia Falco
            affiliation:
                  name:Cardarelli Hospital
                  address:
                     name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nicola Caporaso
            affiliation:
                  name:University of Naples “Federico II”
                  address:
                     name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Targeted Oncology
      issn:
         1776-260X
         1776-2596
      volumeNumber:12
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cardarelli Hospital
      address:
         name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
         type:PostalAddress
      name:Cardarelli Hospital
      address:
         name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
         type:PostalAddress
      name:University of Naples “Federico II”
      address:
         name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
         type:PostalAddress
      name:Cardarelli Hospital
      address:
         name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
         type:PostalAddress
      name:University of Naples “Federico II”
      address:
         name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
         type:PostalAddress
      name:Cardarelli Hospital
      address:
         name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
         type:PostalAddress
      name:Cardarelli Hospital
      address:
         name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
         type:PostalAddress
      name:University of Naples “Federico II”
      address:
         name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Giovan Giuseppe Di Costanzo
      affiliation:
            name:Cardarelli Hospital
            address:
               name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Raffaella Tortora
      affiliation:
            name:Cardarelli Hospital
            address:
               name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
               type:PostalAddress
            type:Organization
      name:Filomena Morisco
      affiliation:
            name:University of Naples “Federico II”
            address:
               name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
               type:PostalAddress
            type:Organization
      name:Luigi Addario
      affiliation:
            name:Cardarelli Hospital
            address:
               name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
               type:PostalAddress
            type:Organization
      name:Maria Guarino
      affiliation:
            name:University of Naples “Federico II”
            address:
               name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
               type:PostalAddress
            type:Organization
      name:Gabriella Cordone
      affiliation:
            name:Cardarelli Hospital
            address:
               name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
               type:PostalAddress
            type:Organization
      name:Luigia Falco
      affiliation:
            name:Cardarelli Hospital
            address:
               name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
               type:PostalAddress
            type:Organization
      name:Nicola Caporaso
      affiliation:
            name:University of Naples “Federico II”
            address:
               name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
      name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
      name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
      name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
      name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
      name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
      name:Department of Transplantation - Liver Unit, Cardarelli Hospital, Naples, Italy
      name:Department of Clinical Medicine and Surgery - Gastroenterology Unit, University of Naples “Federico II”, Naples, Italy
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(171)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.39s.

LINK . SPRINGER . COM {}